Medical News

RSS

Shalala, Cleveland Clinic's Cosgrove weigh in on current health debate

Two health care industry players have views about to handle the current overhaul debate.

8 Sep 2009

Republicans' changed stance on Medicare has historical roots

The GOP's change of stance on Medicare raises questions about its motives, The Associated Press reports in a separate story: "Weren't Republicans against Medicare before they were for it? It's a question vexing Democrats in the fierce battle over President Barack Obama's push for a health care overhaul as the head of the Republican Party has portrayed the GOP as the lone bulwark preventing deep cuts to the popular, government-run health plan for older people."

8 Sep 2009

Visual Management Systems signs a dealer agreement with High Tech Innovations

Visual Management Systems, Inc. (OTCBB: VMSY), a leading developer, manufacturer and provider of video surveillance technologies, is pleased to announce that it has entered into a dealer agreement with High Tech Innovations, a leader in technology infrastructure for the healthcare industry.

8 Sep 2009

Reform measures target health insurance practices such as dropping coverage

Health reform legislation seeks to eliminate practices used by insurance firms known as "rescissions," which firms defend as fraud control. The Washington Post reports in a story headlined "When Your Insurer Says You're No Longer Covered."

8 Sep 2009

MyMedicalRecords PHR offers medical reimbursement for H1N1 affected susbcribers

MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.

8 Sep 2009

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.

8 Sep 2009

Recipients of Charles C. Shepard Award announced

Jill Van Den Bos, a healthcare consultant in Milliman's Denver Health practice, and her colleagues from the Centers for Disease Control and Prevention (CDC) have been named recipients of the prestigious Charles C. Shepard Award.

8 Sep 2009

Microline PENTAX launches rebranded website and new company logo

Microline PENTAX, Inc., a leading manufacturer of reposable instruments for minimally invasive surgery, announced today that it has completed the change of its corporate name to Microline Surgical, Inc. The company will also issue a new logo and launch a rebranded website.

8 Sep 2009

KRYSTEXXA development and treatment failure gout to be presented

Savient Pharmaceuticals, Inc. announced that five abstracts relating to KRYSTEXXA (pegloticase) development and treatment failure gout will be presented at the 2009 ACR/ARHP Annual Scientific Meeting taking place in Philadelphia from October 16-21, 2009.

8 Sep 2009

New iso-active foaming gel delivers active ingredients to hard-to-reach areas of the mouth

The makers of Aquafresh(R) and Sensodyne(R) introduce a breakthrough technology in toothpaste - new iso-active(R) Foaming Gel. Iso-active has a revolutionary delivery system that disperses active ingredients quickly, penetrating those hard-to-reach areas of the mouth.

8 Sep 2009

Valeant develops an acne drug with a low concentration of BPO combined with clindamycin

One of the most widely prescribed drugs for acne vulgaris is benzoyl peroxide (BPO). However, at concentrations of 5-10%, BPO has the potential for skin irritation and dryness leading to poor patient compliance. Increasingly, BPO is combined with clindamycin in a fixed combination where the efficacy effects of the two ingredients are synergistic.

8 Sep 2009

Roche RTS Protein Expression portfolio transferred to RiNA GmbH

Roche and RiNA GmbH of Berlin have agreed to transfer the complete Roche Applied Science RTS Protein Expression portfolio to RiNA GmbH, effective September 15, 2009.

8 Sep 2009

Preliminary results of Phase III Gvhd trials announced by Osiris Therapeutics

Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced preliminary results for two phase III trials evaluating Prochymal for the treatment of acute graft versus host disease (GvHD). GvHD, the most common complication of bone marrow transplantation, is a life-threatening disease for which there is currently no approved treatment. Prochymal showed significant improvements in response rates in difficult-to-treat liver and gastrointestinal GvHD, however neither trial reached its primary endpoint.

8 Sep 2009

Haemonetics acquires SEBRA's blood collection and processing business

Haemonetics Corporation, a global blood management solutions company, and Engineering and Research Associates Inc. (known as "SEBRA(R)"), a leading provider of blood and medical manufacturing technologies, announced today that Haemonetics has acquired the assets of SEBRA's blood collection and processing business for $12.5 million cash. The acquisition is expected to close within the next several weeks.

8 Sep 2009

Largest first responder purchase of Masimo Rad-57 Pulse CO-Oximeters made by the Fire Department of NY

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that the Fire Department of New York City (FDNY) has purchased 86 Masimo Rad-57 Pulse CO-Oximeters as part of their strategic initiative to "improve the survivability of firefighters and victims suffering from carbon monoxide (CO) toxicity."

8 Sep 2009

Pharos Innovations' RPM technology enables healthcare cost reduction

Pharos Innovations announced today that results of the Henry Ford Health System Patient-Centered Team Care program show a 36% reduction in expected all-cause hospital admissions for enrolled heart failure patients after six months of enrollment and a return of 2.3:1 vs. program costs.

8 Sep 2009

Western Dental Services launches digital X-ray imaging program

CDW Healthcare, part of the public sector subsidiary of CDW Corporation and a leading provider of technology products and services to healthcare organizations, today announced that Western Dental Services, Inc. (“Western Dental”) of Orange, Calif., launched an extensive digital X-ray imaging program powered via technology configured and deployed by CDW Healthcare.

8 Sep 2009

eBioscience Corporation announces the acquisition of NatuTec GmbH

eBioscience Corporation, a leading global provider of innovative, high-quality cell analysis reagents announced today the acquisition of NatuTec GmbH, a leading distributor of high-quality biological research reagents located in Frankfurt am Main, Germany.

8 Sep 2009

Exposure to air pollution can cause heart attack

It's well known that measures such as exercise, a healthy diet and not smoking can help reduce high blood pressure, but researchers at the University of Michigan Health System have determined the very air we breathe can be an invisible catalyst to heart disease.

8 Sep 2009

FDA undecided on safety guidelines for hydroquinone use

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US market for physician-dispensed cosmeceutical pigment control products will experience considerable growth in sales over the next five years. MRG's US Markets for Physician-Dispensed Cosmeceuticals 2009 report finds, however, that product safety issues involving hydroquinone, the active ingredient in many pigment control products, have led the Food and Drug Administration (FDA) to second guess the use of the compound in such products.

8 Sep 2009